Biochemical research reagents supplier with 6,000+ small-molecule inhibitors
Selleck Chemicals operates a reagent distribution business serving pharma, biotech, and academic research labs across 38 countries. The hiring profile—858 sales roles against 1 engineering position—reflects a sales-driven, direct-distribution model; concurrent projects around direct-sales-team expansion and replacing agency partnerships indicate aggressive capacity building in their core go-to-market channel. Tech stack (HPLC, LC-MS, FlowJo, ChemDraw, Elasticsearch) supports both product characterization and internal analytics, not software development.
Selleck Chemicals manufactures and distributes biochemical products, including over 6,000 small-molecule kinase inhibitors, screening libraries, natural products, and kits targeting cancer, apoptosis, epigenetics, and cell-signaling research. The company serves pharmaceutical companies, biotech firms, universities, and research institutions through a global operations footprint with headquarters in the US, Asia, and Europe, plus 38 distributors worldwide. They maintain relationships with more than 10,000 customers and offer overnight delivery on in-stock items. Current organizational focus centers on scaling direct sales teams and expanding flow cytometry platform capabilities.
Selleck Chemicals supplies over 6,000 small-molecule kinase inhibitors and screening libraries for drug discovery and systems biology research. Products target cell signaling pathways including MAPK, PI3K/Akt/mTOR, apoptosis, angiogenesis, and JAK/STAT, with applications in cancer, epigenetics, and immunology research.
Yes. The company has 905 active roles with 367 posted in the last 30 days. Hiring is concentrated in sales (858 positions), with smaller teams in marketing (20), research (13), and support (4). Most hires are junior-level.
Other companies in the same industry, closest in size